NANG KUANG — Investor Relations & Filings
Nang Kuang Pharmaceutical Co., Ltd. specializes in the development and manufacture of sterile preparations and high-tech injection products. Established in 1963, the company focuses on acute and critical care, oncology, and preventive medicine. Its core technical portfolio includes Ready-to-Use (RTU) injections, chemotherapy drugs, and environmentally friendly non-PVC large-volume parenterals (LVPs). Operating under cGMP and PIC/S GMP international standards, the company provides a diverse range of products including medical devices, nutritional drips, and anti-aging solutions. As a pioneer in the export of injection products to the Japanese market, Nang Kuang maintains a global footprint across the United States, China, and Southeast Asia. The company also prioritizes sustainable healthcare, implementing circular packaging and green supply chain initiatives to reduce its environmental impact.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年第1季海外子公司投資 | 2026-05-14 | Chinese | |
| 115年第1季財務報告書 — 202601_1752_AI1.pdf | 2026-05-13 | Chinese | |
| 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-08 | Chinese | |
| 115年第1季綜合損益表 | 2026-05-08 | Chinese | |
| 115年第1季資產負債表 | 2026-05-08 | Chinese | |
| 115年第1季權益變動表 | 2026-05-08 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46372403 | 115年第1季海外子公司投資 | 2026-05-14 | Chinese | ||
| 46361106 | 115年第1季財務報告書 — 202601_1752_AI1.pdf | 2026-05-13 | Chinese | ||
| 46944945 | 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-08 | Chinese | ||
| 46944963 | 115年第1季綜合損益表 | 2026-05-08 | Chinese | ||
| 46944958 | 115年第1季資產負債表 | 2026-05-08 | Chinese | ||
| 46944955 | 115年第1季權益變動表 | 2026-05-08 | Chinese | ||
| 46944951 | 115年第1季現金流量表 | 2026-05-08 | Chinese | ||
| 46944969 | 115年4月背書保證與資金貸與 | 2026-05-08 | Chinese | ||
| 46944966 | 115年4月營業收入 | 2026-05-08 | Chinese | ||
| 41460354 | 115年04月內部人持股異動(事後) | 2026-05-05 | Chinese | ||
| 41458106 | 115年04月董事會成員及持股 | 2026-05-05 | Chinese | ||
| 38457874 | 公告本公司115年第一季合併財務報告董事會召開日期 | 2026-04-29 | Chinese | ||
| 37379329 | 115年年報及股東會資料 — 2026_1752_20260528F17.pdf | 2026-04-27 | Chinese | ||
| 37379304 | 115年年報及股東會資料 — 2026_1752_20260528FE1.pdf | 2026-04-27 | English | ||
| 37379128 | 115年年報及股東會資料 — 2026_1752_20260528F01.pdf | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NANG KUANG via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51915/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51915 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51915 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51915 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51915}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NANG KUANG (id: 51915)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.